51. Course of severe coronavirus (COVID-19) in a patient at risk
- Author
-
Valery V. Vasiliev, Elena S. Romanova, Nikolai I. Kuznetsov, and Galina Yu. Startseva
- Subjects
Pediatrics ,medicine.medical_specialty ,ARDS ,Lung ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Clinical course ,macromolecular substances ,General Medicine ,medicine.disease_cause ,medicine.disease ,medicine.anatomical_structure ,medicine ,In patient ,Stage (cooking) ,business ,Cytokine storm ,Coronavirus - Abstract
The article is devoted to the peculiarities of the clinical course of severe coronavirus infection in a 59-year-old woman at risk for comorbidities. Data on the pathogenesis of the severe form of COVID-19 are presented. Prognostic laboratory signs of an unfavorable outcome of coronavirus infection in people at risk are considered. The patient management tactics are described in accordance with the protocol for the treatment of new coronavirus infection. The assessment of patient management at the outpatient stage is given. A new coronavirus infection in at-risk patients can quickly lead to a worsening of the condition, which is manifested by severe lung damage not only according to computed tomography data, but also by the clinical symptom of ARDS. The severity of the condition in this category of patients is due to severe viral aggression, the development of a cytokine storm. The use of the recommended protocol for the treatment of new coronavirus infection in patients at risk does not always give the expected positive result.
- Published
- 2020